158 related articles for article (PubMed ID: 35385606)
21. Optimal treatment and prognostic factors for esthesioneuroblastoma: retrospective analysis of 187 Chinese patients.
Xiong L; Zeng XL; Guo CK; Liu AW; Huang L
BMC Cancer; 2017 Apr; 17(1):254. PubMed ID: 28399835
[TBL] [Abstract][Full Text] [Related]
22. Survival outcomes for stage-matched endoscopic and open resection of olfactory neuroblastoma.
Harvey RJ; Nalavenkata S; Sacks R; Adappa ND; Palmer JN; Purkey MT; Schlosser RJ; Snyderman C; Wang EW; Woodworth BA; Smee R; Havas T; Gallagher R
Head Neck; 2017 Dec; 39(12):2425-2432. PubMed ID: 28945299
[TBL] [Abstract][Full Text] [Related]
23. Esthesioneuroblastoma--what is the optimal treatment?
Eriksen JG; Bastholt L; Krogdahl AS; Hansen O; Joergensen KE
Acta Oncol; 2000; 39(2):231-5. PubMed ID: 10859017
[TBL] [Abstract][Full Text] [Related]
24. Early Stage olfactory neuroblastoma and the impact of resecting dura and olfactory bulb.
Mays AC; Bell D; Ferrarotto R; Phan J; Roberts D; Fuller CD; Frank SJ; Raza SM; Kupferman ME; DeMonte F; Hanna EY; Su SY
Laryngoscope; 2018 Jun; 128(6):1274-1280. PubMed ID: 29226334
[TBL] [Abstract][Full Text] [Related]
25. Microvessel density and Ki-67 labeling index in esthesioneuroblastoma: is there a prognostic role?
Singh L; Ranjan R; Madan R; Arava SK; Deepak RK; Singh MK
Ann Diagn Pathol; 2015 Dec; 19(6):391-6. PubMed ID: 26343569
[TBL] [Abstract][Full Text] [Related]
26. Elective neck irradiation in the management of esthesioneuroblastoma: a systematic review and meta-analysis.
De Virgilio A; Costantino A; Sebastiani D; Russo E; Franzese C; Mercante G; Scorsetti M; Spriano G
Rhinology; 2021 Oct; 59(5):433-440. PubMed ID: 34254061
[TBL] [Abstract][Full Text] [Related]
27. Proposal of a TNM classification-based staging system for esthesioneuroblastoma: More precise prediction of prognosis.
Sun M; Wang K; Qu Y; Zhang J; Zhang S; Chen X; Wang J; Wu R; Zhang Y; Yi J; Xiao J; Xu G; Huang X; Luo J
Head Neck; 2021 Apr; 43(4):1097-1104. PubMed ID: 33301222
[TBL] [Abstract][Full Text] [Related]
28. Comparing Kadish, TNM, and the modified Dulguerov staging systems for esthesioneuroblastoma.
Joshi RR; Husain Q; Roman BR; Cracchiolo J; Yu Y; Tsai J; Kang J; McBride S; Lee NY; Morris L; Ganly I; Tabar V; Cohen MA
J Surg Oncol; 2019 Jan; 119(1):130-142. PubMed ID: 30466166
[TBL] [Abstract][Full Text] [Related]
29. Esthesioneuroblastoma: the role of adjuvant radiation therapy.
Foote RL; Morita A; Ebersold MJ; Olsen KD; Lewis JE; Quast LM; Ferguson JA; O'Fallon WM
Int J Radiat Oncol Biol Phys; 1993 Nov; 27(4):835-42. PubMed ID: 8244813
[TBL] [Abstract][Full Text] [Related]
30. Outcome and Optimal Treatment for Esthesioneuroblastoma in the Era of Intensity-Modulated Radiation Therapy: A Single-Center Experience.
Liu T; Sun Q; Qin W; Chen X; Hu Q
Cancer Manag Res; 2020; 12():8355-8362. PubMed ID: 32982429
[TBL] [Abstract][Full Text] [Related]
31. The clinicopathological spectrum of olfactory neuroblastoma and sinonasal neuroendocrine neoplasms: Refinements in diagnostic criteria and impact of multimodal treatments on survival.
Turri-Zanoni M; Maragliano R; Battaglia P; Giovannardi M; Antognoni P; Lombardi D; Morassi ML; Pasquini E; Tarchini P; Asioli S; Foschini MP; Sessa F; Nicolai P; Castelnuovo P; La Rosa S
Oral Oncol; 2017 Nov; 74():21-29. PubMed ID: 29103747
[TBL] [Abstract][Full Text] [Related]
32. Survival impact of postoperative radiotherapy in patients with olfactory neuroblastoma: 513 cases from the SEER database.
Duo GS; Feng JL; Zhang ZY; Wang LJ
Cancer Radiother; 2022 Sep; 26(5):663-669. PubMed ID: 35249817
[TBL] [Abstract][Full Text] [Related]
33. Long-Term Prognostic Analysis after Endoscopic Endonasal Surgery for Olfactory Neuroblastoma: A Retrospective Study of 13 Cases.
Zhang L; Niu K; Zhu K; Xia C; Yan J; Zhao W; Wei J; Duan M; Zheng G
PLoS One; 2016; 11(11):e0166046. PubMed ID: 27806104
[TBL] [Abstract][Full Text] [Related]
34. Extraprimary Local Recurrence of Esthesioneuroblastoma: Case Series and Literature Review.
Maina IW; Lehrich BM; Goshtasbi K; Su BM; Stubbs VC; Tong CCL; Kohanski MA; Lee JYK; Luu QC; Newman JG; Palmer JN; Adappa ND; Kuan EC
World Neurosurg; 2020 Dec; 144():e546-e552. PubMed ID: 32916346
[TBL] [Abstract][Full Text] [Related]
35. [Prognostic factors and outcome of esthesioneuroblastoma].
Zhao LJ; Gao L; Xu GZ; Li SY; Xiao GL
Zhonghua Zhong Liu Za Zhi; 2005 Sep; 27(9):561-4. PubMed ID: 16438858
[TBL] [Abstract][Full Text] [Related]
36. Olfactory neuroblastoma: the University of Erlangen-Nuremberg experience 1975-2000.
Constantinidis J; Steinhart H; Koch M; Buchfelder M; Schaenzer A; Weidenbecher M; Iro H
Otolaryngol Head Neck Surg; 2004 May; 130(5):567-74. PubMed ID: 15138422
[TBL] [Abstract][Full Text] [Related]
37. Regional Recurrences and Hyams Grade in Esthesioneuroblastoma.
Ziai H; Yu E; Weinreb I; Perez-Ordonez B; Yao CMKL; Xu W; Yang D; Witterick IJ; Monteiro E; Gilbert RW; Irish JC; Gullane PJ; Goldstein DP; Ringash J; Bayley A; de Almeida JR
J Neurol Surg B Skull Base; 2021 Dec; 82(6):608-614. PubMed ID: 34745827
[No Abstract] [Full Text] [Related]
38. Esthesioneuroblastoma - a clinicopathologic study and role of DNA topoisomerase alpha.
Sharma S; Sharma MC; Johnson MH; Lou M; Thakar A; Sarkar C
Pathol Oncol Res; 2007; 13(2):123-9. PubMed ID: 17607373
[TBL] [Abstract][Full Text] [Related]
39. Esthesioneuroblastoma: updating histologic grading as it relates to prognosis.
Gallagher KK; Spector ME; Pepper JP; McKean EL; Marentette LJ; McHugh JB
Ann Otol Rhinol Laryngol; 2014 May; 123(5):353-8. PubMed ID: 24668054
[TBL] [Abstract][Full Text] [Related]
40. Comparing Kadish and Modified Dulguerov Staging Systems for Olfactory Neuroblastoma: An Individual Participant Data Meta-analysis.
Arnold MA; Farnoosh S; Gore MR
Otolaryngol Head Neck Surg; 2020 Sep; 163(3):418-427. PubMed ID: 32286935
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
